Ra Capital Management, L.P. Axsome Therapeutics, Inc. Transaction History

Ra Capital Management, L.P.

$6.17 Billion
Q4 2024

A detailed history of Ra Capital Management, L.P. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 1,000,000 shares of AXSM stock, worth $138 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares

1,000,000

Previous 1,000,000 -0.0%

Holding current value

$138 Million

Previous $89.9 Million 5.83%

% of portfolio

1.37%

Previous 1.25%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$65.72 - $80.5 $65.7 Million - $80.5 Million	1,000,000 New	1,000,000 $80.5 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $57.4 Million - $83.6 Million	1,000,000 New	1,000,000 $79.6 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $58.4 Million - $90.4 Million	1,000,000 New	1,000,000 $71.9 Million
Q3 2021 Nov 15, 2021	SELL	$19.91 - $68.26 $33 Million - $113 Million	-1,655,447 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $25.2 Million - $32.9 Million	-379,685 Reduced 18.66%	1,655,447 $135 Million
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $6.53 Million - $12.9 Million	131,038 Added 6.88%	2,035,132 $167 Million
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $63.3 Million - $156 Million	1,536,278 Added 417.68%	1,904,094 $112 Million
Q4 2019 Feb 14, 2020	SELL	$16.71 - $106.24 $4.96 Million - $31.5 Million	-296,569 Reduced 44.64%	367,816 $38 Million
Q3 2019 Nov 14, 2019	SELL	$20.24 - $29.16 $13.7 Million - $19.7 Million	-676,443 Reduced 50.45%	664,385 $13.4 Million
Q2 2019 Aug 14, 2019	SELL	$13.46 - $25.75 $26.3 Million - $50.3 Million	-1,952,961 Reduced 59.29%	1,340,828 $34.5 Million
Q1 2019 May 15, 2019	BUY	$2.63 - $16.34 $8.66 Million - $53.8 Million	3,293,789 New	3,293,789 $46.9 Million

Others Institutions Holding AXSM

# of Institutions

351

Shares Held

36.3M

Call Options Held

1.77M

Put Options Held

1.16M

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5.91B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.

Account

Ra Capital Management, L.P. Axsome Therapeutics, Inc. Transaction History